Case Reports
4 July 2025

Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1294
Views
1260
Downloads

Authors

Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects the axial skeleton, often beginning in the sacroiliac joints, but accompanied also by other signs, including enthesitis, lung fibrosis and eye involvement. AS generally occurs in the second or third decade of life with inflammatory low back pain and has a strong relation with HLA-B27. The objective of the treatment until the end of the 90’s was to ameliorate pain and stiffness and preserve function (1). Nonselective nonsteroidal antiinflammatory drugs (NSAIDs), cyclooxygenase-2 selective inhibitors, and nonpharmalogic interventions, such as physiotherapy, exercise, education, and lifestyle modifications were the basis of the management. Therapy with agents like sulphasalazine was administered for peripheral arthritis (1, 2)...

Altmetrics

Downloads

Download data is not yet available.

Citations

How to Cite



Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report. (2010). Reumatismo, 62(4), 283-285. https://doi.org/10.4081/reumatismo.2010.283